Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo

p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death

Bjørkøy, G., Lamark, T., Brech, A., Outzen, H., Perander, M., Øvervatn, A., Stenmark, H., & Johansen, T. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200507002 · Cited by 3,276

Dissection of the Autophagosome Maturation Process by a Novel Reporter Protein, Tandem Fluorescent-Tagged LC3

Kimura, S., Noda, T., & Yoshimori, T. (2007) · Autophagy · doi:10.4161/auto.4451 · Cited by 2,278

Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice.

Komatsu, M., Waguri, S., Koike, M., Sou, Y.-S., Ueno, T., Hara, T., Mizushima, N., Iwata, J.-I., Ezaki, J., Murata, S., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.035 · Cited by 2,124

In Vivo Analysis of Autophagy in Response to Nutrient Starvation Using Transgenic Mice Expressing a Fluorescent Autophagosome Marker

Mizushima, N., Yamamoto, A., Matsui, M., Yoshimori, T., & Ohsumi, Y. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-09-0704 · Cited by 2,105

Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy

Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024

Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein

Lewis, J., McGowan, E., Rockwood, J., Melrose, H., Nacharaju, P., Van Slegtenhorst, M., Gwinn-Hardy, K., Murphy, M. P., Baker, M., Yu, X., et al. (2000) · Nature Genetics · doi:10.1038/78078 · Cited by 1,371

Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40

Haar, E. V., Lee, S.-I., Bandhakavi, S., Griffin, T. J., & Kim, D. (2007) · Nature Cell Biology · doi:10.1038/ncb1547 · Cited by 1,227

Beclin 1 Forms Two Distinct Phosphatidylinositol 3-Kinase Complexes with Mammalian Atg14 and UVRAG

Itakura, E., Kishi, C., Inoue, K., & Mizushima, N. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-01-0080 · Cited by 1,176

Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis

Takahashi, Y., Coppola, D., Matsushita, N., Cualing, H. D., Sun, M., Sato, Y., Liang, C., Jung, J. U., Cheng, J. Q., Mul, J. J., et al. (2007) · Nature Cell Biology · doi:10.1038/ncb1634 · Cited by 964

Levosimendan inhibits disulfide tau oligomerization and ameliorates tau pathology in TauP301L-BiFC mice

Lim, S., Shin, S., Sung, Y., Lee, H. E., Kim, K. H., Song, J. Y., Lee, G., Aziz, H., Lukianenko, N., Kang, D. M., et al. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-00959-5 · Cited by 16

Overcoming breast cancer cell treatment resistance by optimizing sonodynamic therapy and radiation sensitizers on lncRNA PVT1 and miR-1204 expression

Neshasteh‐Riz, A., Hormozi‐Moghaddam, Z., Kichi, Z. A., Taheri, S. M., Amini, S. M., & Aghaei, A. (2024) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2024.104433 · Cited by 14

Protective Effects of Humanin on Okadaic Acid-Induced Neurotoxicities in Cultured Cortical Neurons

Zhao, J., Wang, D., Li, L., Zhao, W., & Zhang, C. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1410-3 · Cited by 14

α-Synuclein and tau, two targets for dementia

Silva, M., Caro, V., Guzmán, C., Perry, G. L., Areche, C., & Cornejo, A. (2020) · Studies in natural products chemistry · doi:10.1016/b978-0-12-819483-6.00001-1 · Cited by 15

Experimental Disease-Modifying Agents for Frontotemporal Lobar Degeneration

Giunta, M., Solje, E., Gardoni, F., Borroni, B., & Benussi, A. (2021) · Journal of Experimental Pharmacology · doi:10.2147/jep.s262352 · Cited by 15

The tau of PSP: A long road to treatment

Golbe, L. I. (2014) · Movement Disorders · doi:10.1002/mds.25855 · Cited by 14

Immunotherapy in Alzheimer’s Disease: Current Status and Future Directions

Vashisth, K., Sharma, S., Ghosh, S., Babu, M. A., Ghosh, S., Iqbal, D., Kamal, M., Almutary, A. G., Jha, S. K., Ojha, S. K., et al. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-230603 · Cited by 13

An AMPK-dependent regulatory pathway in tau-mediated toxicity

Galasso, A., Cameron, C. S., Frenguelli, B. G., & Moffat, K. G. (2017) · Biology Open · doi:10.1242/bio.022863 · Cited by 13

Proteomic Analysis of Hydromethylthionine in the Line 66 Model of Frontotemporal Dementia Demonstrates Actions on Tau-Dependent and Tau-Independent Networks

Schwab, K., Melis, V., Harrington, C. R., Wischik, C. M., Magbagbeolu, M., Theuring, F., & Riedel, G. (2021) · Cells · doi:10.3390/cells10082162 · Cited by 11

Multifunctional compounds lithium chloride and methylene Blue attenuate the negative effects of diisopropylfluorophosphate on axonal transport in rat cortical neurons

Naughton, S. X., Beck, W. D., Wei, Z., Wu, G., & Terry, A. V. (2020) · Toxicology · doi:10.1016/j.tox.2020.152379 · Cited by 12

Hierarchical Protofilament Intertwining Rules the Formation of Mixed‐Curvature Amyloid Polymorphs

Zhou, J., Assenza, S., Tatlı, M., Tian, J., Ilie, I. M., Starostin, E. L., Caflisch, A., Knowles, T. P. J., Dietler, G., Ruggeri, F. S., et al. (2024) · Advanced Science · doi:10.1002/advs.202402740 · Cited by 11

Chaperone-Mediated Responses and Mitochondrial–Endoplasmic Reticulum Coupling: Emerging Insight into Alzheimer’s Disease

Singh, M. K., Fu, M., Han, S., Ranbhise, J. S., Choe, W., Kim, S. S., & Kang, I. (2025) · Cells · doi:10.3390/cells14151179 · Cited by 11

Treatment implications of C9ORF72

Sha, S. J., & Boxer, A. L. (2012) · Alzheimer s Research & Therapy · doi:10.1186/alzrt149 · Cited by 11

Recent Advances Towards Diagnosis and Therapeutic Fingerprinting for Alzheimer’s Disease

Pradhan, L. K., Sahoo, P. K., Chauhan, S., & Das, S. K. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02009-7 · Cited by 11

Gap-Plasmon-Enhanced High-Spatial-Resolution Imaging by Photothermal-Induced Resonance in the Visible Range

Zhou, J., Smirnov, A., Dietler, G., & Sekatskii, S. K. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b03844 · Cited by 10

Recent Advancements in Strategies for Abnormal Protein Clearance in Alzheimer's Disease

Zhuang, J., Gao, J., Yin, Y., Gong, B., Ji, W., Chen, X., Li, P., Cheng, W., Zhao, Y., & He, B. (2022) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557522666220214092824 · Cited by 10

Six Decades of Dopamine Hypothesis: Is Aryl Hydrocarbon Receptor the New D2?

Sfera, A. (2023) · Reports — Medical Cases Images and Videos · doi:10.3390/reports6030036 · Cited by 10

Twenty years of therapeutic development in tauopathy mouse models: a scoping review

Langness, V. F., Simmons, D. A., McHugh, T. L. M., Butler, R. R., Zhou, J., Liu, H., Yang, T., Ellerby, L., & Longo, F. M. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70578 · Cited by 9

Maintenance and Decline of Neuronal Lysosomal Function in Aging

Zhong, R., & Richardson, C. E. (2025) · Cells · doi:10.3390/cells14241976 · Cited by 8

Graptopetalum paraguayense Extract Ameliorates Proteotoxicity in Aging and Age-Related Diseases in Model Systems

Chen, Y.-X., Le, P. T. N., Tzeng, T.-T., Tran, T.-H., Nguyen, A. T., Cheng, I. H.-J., Huang, C. F., Shiao, Y., & Ching, T. (2021) · Nutrients · doi:10.3390/nu13124317 · Cited by 8

HMTM-Mediated Enhancement of Brain Bioenergetics in a Mouse Tauopathy Model Is Blocked by Chronic Administration of Rivastigmine

Santos, R. X., Melis, V., Goatman, E. A., Leith, M., Baddeley, T. C., Storey, J. M. D., Riedel, G., Wischik, C. M., & Harrington, C. R. (2022) · Biomedicines · doi:10.3390/biomedicines10040867 · Cited by 8

Inhibition of Tau aggregation with BSc3094 reduces Tau and decreases cognitive deficits in rTg4510 mice

Anglada‐Huguet, M., Rodrigues, S., Hochgräfe, K., Mandelkow�, E., & Mandelkow, E. (2021) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12170 · Cited by 7

Sex differences in response to obesity and caloric restriction on cognition and hippocampal measures of autophagic-lysosomal transcripts and signaling pathways

Baer, S. B., Dorn, A. D., & Osborne, D. M. (2024) · BMC Neuroscience · doi:10.1186/s12868-023-00840-1 · Cited by 7

Strategizing the Development of Alzheimer’s Therapeutics

Davis, J. B., & Couch, R. D. (2014) · Advances in Alzheimer s Disease · doi:10.4236/aad.2014.33011 · Cited by 7

Toluidine blue O attenuates tau phosphorylation in N2a-APPSwe cells

Önder, S., Biberoğlu, K., Yuksel, M., & Tacal, Ö. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.110126 · Cited by 8

Mechanismen der Alzheimer-Krankheit

Busche, M. A., Staufenbiel, M., Willem, M., Haass, C., & Förstl, H. (2016) · Der Nervenarzt · doi:10.1007/s00115-015-0041-5 · Cited by 7

Targeting selective autophagy in CNS disorders by small-molecule compounds

Zheng, Y., Zhou, Z., Liu, M., & Chen, Z. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108729 · Cited by 6

Proteostasis and Secondary Proteinopathy in Alzheimer?s Disease

Xu, D. R. B. G., & Notterpek, L. M. (2014) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000145 · Cited by 6

SMMDB: a web-accessible database for small molecule modulators and their targets involved in neurological diseases

Mishra, S. K., Jain, N., Shankar, U., Tawani, A., Mishra, A., & Kumar, A. (2018) · Database · doi:10.1093/database/bay082 · Cited by 6

The engagement of microglia in tau-targeted immunotherapy in Alzheimer’s disease

Palova, D., Csokova, N. T., Markova, K., Kontseková, E., Kováčech, B., & Žilková, M. (2021) · General Physiology and Biophysics · doi:10.4149/gpb_2021029 · Cited by 6

Kinase inhibition in Alzheimer’s disease

Bagheri, S., & Saboury, A. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91287-7.00003-x · Cited by 6

Autophagy and tau protein

Hamano, T., & Endo, Y. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89906-2.00006-x · Cited by 7

Hydromethylthionine rescues synaptic SNARE proteins in a mouse model of tauopathies: Interference by cholinesterase inhibitors

Schwab, K., Lauer, D., Magbagbeolu, M., Theuring, F., Gąsiorowska, A., Zadrożny, M., Harrington, C. R., Wischik, C. M., Niewiadomska, G., & Riedel, G. (2024) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2024.110955 · Cited by 6

Development of P301S tau seeded organotypic hippocampal slice cultures to study potential therapeutics

McCarthy, J. M., Virdee, J. K., Brown, J., Ursu, D., Ahmed, Z., Cavallini, A., & Nuthall, H. N. (2021) · Scientific Reports · doi:10.1038/s41598-021-89230-3 · Cited by 7

Axon Injury-Induced Autophagy Activation Is Impaired in a C. elegans Model of Tauopathy

Ko, S. H., Gonzalez, G., Liu, Z., & Chen, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228559 · Cited by 5

Methylene blue promotes quiescence of rat neural progenitor cells

Xie, L., Choudhury, G. R., Wang, J., Park, Y. H., Liu, R., Yuan, F., Zhang, C.-L., Yorio, T., Jin, K., & Yang, S.-H. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00315 · Cited by 5

Long-term depression-related tau phosphorylation is enhanced by methylene blue in healthy rat hippocampus

Süer, C., Demircan, N. Y., Barutçu, Ö., Tan, B., & Dursun, N. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00254-y · Cited by 5

Towards sustainable removal of methylthioninium chloride by using adsorption-electroradical regeneration

Ouiriemmi, I., Rosales, E., Pazos, M. M., Gadri, A., Ammar, S., & Sanromán, M. Á. (2018) · Chemosphere · doi:10.1016/j.chemosphere.2018.07.019 · Cited by 5

Improvement in behavioral symptoms, motor impairment and activities of daily living in a patient with the behavioral variant of frontotemporal dementia under treatment with methylene blue

Adler, G., & Mautes, A. E. M. (2014) · Geriatric Mental Health Care · doi:10.1016/j.gmhc.2014.06.001 · Cited by 5

An Insight into the Protein Aggregation in Alzheimer’s Disease and its Inhibition

Khan, A. B., & Khan, R. H. (2023) · Protein and Peptide Letters · doi:10.2174/0109298665247757231020044633 · Cited by 4

Methylene Blue Attenuates Impaired Cognitive Functions and Reduces Hippocampal Aβ Levels and Oxidative Stress in D-Galactose-Induced Alzheimer’s Disease Mouse Model

Kazkayası, İ., & Telli, G. (2024) · Biology Bulletin · doi:10.1134/s106235902360455x · Cited by 4

Prospects and Challenges for Alzheimer Therapeutics

Wolfe, M. S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00023-x · Cited by 5

The Potential of Small Molecules in Preventing Tau Oligomer Formation and Toxicity

Gerson, J. E., Cascio, F. L., & Kayed, R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803690-7.00006-5 · Cited by 4

A chemogenomic approach is required for effective treatment of amyotrophic lateral sclerosis

Pampalakis, G., Angelis, G., Zingkou, E., Vekrellis, K., & Sotiropoulou, G. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.657 · Cited by 4

Restoration of autophagy-lysosomal function via transcranial focused ultrasound stimulation ameliorates β-amyloid pathology and cognitive deficits in an Alzheimer’s disease model

Wang, M., Zhang, B., Guo, R., Wang, H., Wu, D., Peng, X., Guo, H., Duan, J., Yang, W., Ren, P., et al. (2026) · Ultrasonics · doi:10.1016/j.ultras.2026.108075 · Cited by 3

High-throughput screening identifies a novel small-molecule modulator of Hsp70 that selectively enhances ubiquitination and degradation of misfolded neuronal NO synthase

Garcia, A. M., Davis, A. K., Martinez-Ramos, C., Morishima, Y., Lau, M., Xu, E. L., Sunil, A., Zhang, H., Alt, A. J., Lieberman, A. P., et al. (2024) · Molecular Pharmacology · doi:10.1016/j.molpha.2024.100008 · Cited by 3

Stimulation of Tau Degradation

Quintanilla, R. A., Cabezas-Opazo, F., Pallo, S. P., Chesser, A. S., & Johnson, G. V. W. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00013-7 · Cited by 3

Molecular Pathways in Alzheimer’s Disease and Cognitive Function

Chen, X., Reichert, M. C., & Gan, L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802851-3.00005-x · Cited by 3

Therapeutics of Alzheimer’s Disease

Herrera-Rivero, M., & Emiliano, G. (2011) · InTech eBooks · doi:10.5772/27990 · Cited by 3

Inhibition of Tau Aggregation as a Basis for Treatment and Prevention of Alzheimer’s Disease

Wischik, C. M., Storey, J. M. D., Wischik, D., & Harrington, C. R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00015-0 · Cited by 3

Methotrimeprazine exerts antiviral and neuroprotective effects in Japanese encephalitis virus infection through activation of adaptive ER stress and autophagyPreprint

Prajapat, S. K., Mishra, L., Khera, S., Owusu, S. D., Ahuja, K., Sharma, P., Singh, R., Mahajan, D., Banerjee, A. K., Motiani, R. K., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.05.535645 · Cited by 3

Advances in Diagnostics and Treatments for Alzheimer’s Disease

Sunderland, A., Thatcher, A. L., Rackley, E. V., & Kuruvilla, T. (2025) · British Journal of Hospital Medicine · doi:10.12968/hmed.2025.0492 · Cited by 4

Targeting Assembly and Disassembly of Protein Aggregates

Seneci, P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801944-3.00006-0 · Cited by 2

Mitochondria in Alzheimer disease : regulatory mechanisms and cell death

Hedskog, L. (2012) · Figshare · Cited by 2

Levosimendan prevents tau pathology by inhibiting disulfide-linked tau oligomerization posing as a promising anti-tau therapeuticsPreprint

Kim, Y. K., Lim, S., Shin, S., Lee, H. E., Song, J. Y., Sung, Y., Lee, G., Yu, B.-Y., Aziz, H., Lukianenko, N., et al. (2020) · doi:10.21203/rs.3.rs-128169/v1 · Cited by 2

A variant of the autophagic receptor NDP52 counteracts phospho-TAU accumulation and emerges as a protective factor for Alzheimer DiseasePreprint

Mattioni, A., Carsetti, C., Bruqi, K., Caputo, V., Cianfanelli, V., Bacalini, M. G., Casa, M., Gabelli, C., Giardina, E., Cestra, G., et al. (2024) · medRxiv · doi:10.1101/2024.08.13.24311780 · Cited by 2

Tau-Centric Therapies for Treating Alzheimer’s Disease

Quraishe, S., Cowan, C. M., & Mudher, A. K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803690-7.00005-3 · Cited by 1

Anti-cis P-tau attenuates tauopathy and enhances cognitive function following global cerebral ischemia in mice

Sadeghzadeh, J., Roqanian, S., Jafarzadeh, J., Zangbar, H. S., Nakhjiri, E., Kalan, A. E., Farhoudi, M., Ahmadian, S., Shahabi, P., & Shahpasand, K. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114834 · Cited by 1

Signaling pathway cross talk in Alzheimer's

Godoy, J. A., Ríos, J. A., Zolezzi, J. M., Braidy, N., & Inestrosa, N. C. (2014) · Cited by 1

Alzheimer’s Disease and Mechanism-Based Attempts to Enhance Cognition

Draffin, J. E., Knafo, S., & Heneka, M. T. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-417042-1.00009-7 · Cited by 1

Drug discovery in Alzheimer’s disease by regulating autophagy

Hamano, T., & Endo, Y. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89906-2.00002-2 · Cited by 1

(−)‐Epicatechin Rescues Memory Deficits by Activation of Autophagy in a Mouse Model of Tauopathies

Wu, Y., Li, T., Jiang, X., Ling, J., Zhao, Z., Zhu, J., Chen, C., Liu, Q., Yang, X., Shen, X., et al. (2025) · MedComm · doi:10.1002/mco2.70144 · Cited by 2

Targets and Strategies Toward the Development of Alzheimer Therapeutics

Wolfe, M. S. (2016) · Topics in medicinal chemistry · doi:10.1007/7355_2016_14 · Cited by 2

Crosstalk Between Autophagy and Nutrigenomics in Neurodegenerative Diseases

Russell, A. E., Badr, A., Rai, A., Carafice, C., Rai, A., Daily, K. P., Whitham, O. D., Amer, A. O., Brown, C. M., & Dakhlallah, D. A. (2022) · Nutritional neurosciences · doi:10.1007/978-981-16-9205-5_13 · Cited by 1

Dyrk1a inhibition with the Novel Compound DYR533: A Cross-Disease Therapeutic Strategy Targeting Amyloidosis, Tau Pathogenesis, and NeuroinflammationPreprint

Bartholomew, S. K., Turk, J., Winslow, W., Foley, C., Shaw, A. Y., Rokey, S., Tallino, S., Judd, J. M., Beach, T. G., Serrano, G. E., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.20.700091 · Cited by 1

Past, Present, and Future: The Behavioral Sciences.

Darley, J. G. (1971) · Contemporary Psychology · doi:10.1037/014015

Functional implications of tau-fyn interactions in Alzheimer's disease

Lau, H. W. D. (2015)

A protective role of autophagy in a Drosophila model of Friedreich's ataxia (FRDA)

Wang, L. (2015) · Human Biology

Immunotherapy for the Treatment of Alzheimer’s Disease

Farooqui, A. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809937-7.00009-4

The role of tau in Alzheimer’s Disease: Effects of Lys-280 and Lys-281 acetylation on tau function and structure

Constance, B. H. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/jk28-gv66

Azul de Metileno na Paralisia Supranuclear Progressiva, uma possibilidade?

Vilaça, C. D. O., Pessôa, B. L., Orsini, M. A., Reis, C. H. M., Azizi, M. A. A., Moreno, A. M., Bastos, V. H., & Leite, M. A. A. (2020) · Revista Neurociências · doi:10.34024/rnc.2020.v28.10210

Mammalian target of rapamycin complexes

Querfurth, H. W., & Lee, H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815868-5.00021-9

Revisiting Alzheimer’s Disease

Salwa, & Kumar, L. (2020) · Springer eBooks · doi:10.1007/978-981-15-5167-3_7

Neuronal NOX4 knockdown alleviates pathological tau-related alterations in a humanized mouse model of tauopathyPreprint

Luengo, E., Trigo-Alonso, P., Fernández‐Mendívil, C., Núñez, Á., del Campo, M., Porrero, C., García‐Magro, N., Negredo, P., Sánchez‐Ramos, C., Bernal, J. A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.14.338954

Chemical Probes in Cellular Assays for Target Validation and Screening in Neurodegeneration

Silva, A. M., Cederbalk, A., Ebner, D. V., & Daniel, E. D. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781839160745-00276

Emerging Potential Role of Autophagy to Modulate Aggresome Formation: Insights Molecular Treatment of Alzheimer’s DiseasePreprint

Rahman, M. A., Rahman, M. H., Mamun-Or-Rashid, A. N. M., Hwang, H., & Rhim, H. (2021) · Preprints.org · doi:10.20944/preprints202101.0062.v1

A chemogenomic approach seems indispensable for effective treatment of amyotrophic lateral sclerosisPreprint

Pampalakis, G., Angelis, G., Kastana, P., Vekrellis, K., & Sotiropoulou, G. (2021) · doi:10.22541/au.161193502.21521333/v1

Exercise-Mediated Autophagy and Alzheimer’s Disease

Kou, X., Zhang, M., Zhang, H., Kirberger, M., & Chen, N. (2021) · Springer eBooks · doi:10.1007/978-981-16-4525-9_7

New therapeutic opportunities for Alzheimer disease

Jang, J. (2022) · Journal of Geriatric Neurology · doi:10.53991/jgn.2021.00017

A Brief Overview of Pathological Tau and Inhibitors and Modifiers of Tau Aggregation for Treatment of Tauopathies

Manthapuri, S. S., & Davis, E. (2021) · Journal of Student Research · doi:10.47611/jsrhs.v10i4.2468

Bringing the Spotlight to Tau and TDP-43 in Frontotemporal Dementia: A Review of Promising Chemical Compounds

Villalobos-Nova, K., Monroy-Moya, S., Maulen-Peñaloza, J., Pinto, G. C. M., & Cornejo, A. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220508175340

Emerging Therapeutic Approaches for Neurodegenerative Diseases

Ugale, R. R., & Sarode, L. P. (2022) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815040913122010013

Neuropharmacology in Alzheimer and Huntington Disease

Gupta, B., & Rohatgi, K. (2022) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815040913122010015

Avaliação antitumoral da terapia fotodinâmica com azul de metileno em células neoplásicas mamárias

de Souza, Á. C. (2022) · doi:10.34019/ufjf/di/2022/00179

Sex differences in response to obesity and caloric restriction on cognition and hippocampal markers of autophagic-lysosomal pathway functionPreprint

Baer, S. B., Dorn, A. D., & Osborne, D. M. (2023) · Research Square · doi:10.21203/rs.3.rs-2724928/v1

Methylene blue treatment on Alzheimer and inflammatory bowel disease

Öğünç, B., Ramoğlu, N., & Sakin, I. (2021) · Demiroglu Science University Florence Nightingale Journal of Medicine · doi:10.5606/fng.btd.2020.25053

Potential of methylene blue fluorescence angiography for multiple intraoperative tissue perfusion assessments in plastic and reconstructive surgery: current knowledge and prospects

Heuvelings, D. J. I., Hillege, L. E., Al‐Taher, M., & Schols, R. M. (2025) · Frontiers in Surgery · doi:10.3389/fsurg.2025.1681731

Additional file 2 of Sex differences in response to obesity and caloric restriction on cognition and hippocampal measures of autophagic-lysosomal transcripts and signaling pathways

Baer, S. B., Dorn, A. D., & Osborne, D. M. (2024) · Figshare · doi:10.6084/m9.figshare.26658469

Additional file 3 of Sex differences in response to obesity and caloric restriction on cognition and hippocampal measures of autophagic-lysosomal transcripts and signaling pathways

Baer, S. B., Dorn, A. D., & Osborne, D. M. (2024) · Figshare · doi:10.6084/m9.figshare.26658472

Additional file 1 of Sex differences in response to obesity and caloric restriction on cognition and hippocampal measures of autophagic-lysosomal transcripts and signaling pathways

Baer, S. B., Dorn, A. D., & Osborne, D. M. (2024) · Figshare · doi:10.6084/m9.figshare.26658466

Drug Discovery for Alzheimer’s Disease: Current Status

Wolfe, M. S. (2026) · Topics in medicinal chemistry · doi:10.1007/7355_2026_186

Beauvericin promotes autophagy and mitophagy by activating NIPSNAP2

Zhao, X., Zhang, R., Ma, Y. L., Yu, T., Li, J., Liu, A., Hu, J. B., Wu, J., Zhang, L., Ye, M., et al. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.109885

Glycopolymers as emerging modulators of Amyloid-β aggregation: structure-activity relationships and therapeutic potential

Cardoso, E., Serra, A. C., Coelho, J. F. J., & Pereira, P. (2026) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2026.125572

Omipalisib reduces hyperphosphorylated tau protein by modulating mTOR-autophagy pathway

Hwang, H., Kim, N., Jeon, S., Lee, Y., Son, J., Jeon, S. H., Lee, Y., Gee, M. S., Inn, K., & Lee, J. K. (2026) · PLoS ONE · doi:10.1371/journal.pone.0352120

Small molecular chaperones regulate protein quality control in neurodegenerative diseases

Rangappa, N., Mishra, A., & Chinnathambi, S. (2026) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2026.06.006

Targeting Autophagy in Alzheimer's Disease: Role of the AMPK/mTOR Pathway and Drug Repurposing

Dubey, A., Chaurasia, A., Ansari, Z. A., Kushwaha, S. K., Saraf, I., Kashaw, S. K., Swami, R., & Kushwah, V. (2026) · Drug Development Research · doi:10.1002/ddr.70344

Tau physiology and pathology: impacts on cellular structures and neurodegenerative diseases

Akbari, V., & Bahramikia, S. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02328-w

BindingDB Entry 50016393: Small molecule therapeutics for tauopathy in Alzheimer's disease: Walking on the path of most resistance.

BindingDB (2023) · UC San Diego · doi:10.7270/q2cv4nqf

BindingDB Entry 50042999: Progress and developments in tau aggregation inhibitors for Alzheimer disease.

BindingDB (2014) · UC San Diego · doi:10.7270/q2ht2qqd

BindingDB Entry 50002303: Tau protein aggregation in Alzheimer's disease: An attractive target for the development of novel therapeutic agents.

BindingDB (2020) · UC San Diego · doi:10.7270/q2zp48qf

P3‐331: Methylene blue reduced tau phosphorylation and aggregation in P301L tau transgenic mice

Hosokawa, M., Arai, T., Nonaka, T., Yamashita, M., Masuda‐Suzukake, M., Hasegawa, M., & Akiyama, H. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.05.1555

Methylene Blue Reduced Abnormal Tau Accumulation in P301L Tau Transgenic Mice

Hosokawa, M., Arai, T., Masuda‐Suzukake, M., Nonaka, T., Yamashita, M., Akiyama, H., & Hasegawa, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052389 · Cited by 95

Methylene blue upregulates Nrf2/ARE genes and prevents tau-related neurotoxicity

Stack, C., Jainuddin, S., Elipenahli, C., Gerges, M., Starkova, N. N., Starkov, A. A., Jové, M., Portero‐Otín, M., Launay, N., Pujol, A., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu080 · Cited by 168

Modulation of mitochondrial function by methylene blue and phosphorylated tau protein

Hroudová, J., Škutová, K., Krasňan, S., & Fišar, Z. (2026) · European Psychiatry · doi:10.1192/j.eurpsy.2026.11617

Autophagy and tau protein

Hamano, T., & Endo, Y. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89906-2.00006-x · Cited by 7